Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire Roddie

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Ejhaem|October 17, 2024
Single-centre experience of implementing physiotherapist-led prehabilitation for chimeric antigen receptor T cell therapyOrla McCourt, Paul Maciocia, Claire Roddie, et al.
Haematologica|April 30, 2025
Clonal evolution and the risk of secondary myeloid neoplasia following chimeric antigen receptor T-cell therapyFrancesca Sillito, Alexandros Rampotas, Kathleen Cheok, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 23, 2020
Cardiovascular Events Associated with Chimeric Antigen Receptor T Cell Therapy: Cross-Sectional FDA Adverse Events Reporting System AnalysisAvirup Guha, Daniel Addison, Prantesh Jain, et al.
Ejhaem|December 18, 2024
CD19-targeting chimeric antigen receptor T-cell therapy is safe and effective for intra-cardiac B cell non-Hodgkin lymphomaDaniel H Chen, Maeve O'Reilly, Kathleen P Cheok, et al.
Cytotherapy|December 13, 2022
A novel predictive algorithm to personalize autologous T-cell harvest for chimeric antigen receptor T-cell manufactureMaeve A O'Reilly, Aman Malhi, Kathleen P L Cheok, et al.
Haematologica|April 2, 2026
CAR-T therapy for relapsed/refractory large B-cell lymphoma in people living with HIV: efficacy, toxicity and treatment considerationsAngela Hwang, Amy A Kirkwood, Prudence Hardefeldt, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 13, 2006
Long-term outcomes of myeloablation and autologous transplantation of relapsed acute myeloid leukemia in second remission: a British Society of Blood and Marrow Transplantation registry studyAndrew D Chantry, John A Snowden, Charles Craddock, et al.
Molecular Therapy. Methods & Clinical Development|October 27, 2023
Large-scale manufacturing of base-edited chimeric antigen receptor T cellsRosie Woodruff, Farhaan Parekh, Katarina Lamb, et al.
Bone|April 29, 2006
Elevated serum FGF23 concentrations in plasma cell dyscrasiasInge Stewart, Claire Roddie, Anthony Gill, et al.
Hemasphere|March 4, 2024
High pretreatment disease burden as a risk factor for infectious complications following CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphomaMaeve A O'Reilly, Lorna Neill, Simon M Collin, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Ejhaem|October 17, 2024
Single-centre experience of implementing physiotherapist-led prehabilitation for chimeric antigen receptor T cell therapyOrla McCourt, Paul Maciocia, Claire Roddie, et al.
Haematologica|April 30, 2025
Clonal evolution and the risk of secondary myeloid neoplasia following chimeric antigen receptor T-cell therapyFrancesca Sillito, Alexandros Rampotas, Kathleen Cheok, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 23, 2020
Cardiovascular Events Associated with Chimeric Antigen Receptor T Cell Therapy: Cross-Sectional FDA Adverse Events Reporting System AnalysisAvirup Guha, Daniel Addison, Prantesh Jain, et al.
Ejhaem|December 18, 2024
CD19-targeting chimeric antigen receptor T-cell therapy is safe and effective for intra-cardiac B cell non-Hodgkin lymphomaDaniel H Chen, Maeve O'Reilly, Kathleen P Cheok, et al.
Cytotherapy|December 13, 2022
A novel predictive algorithm to personalize autologous T-cell harvest for chimeric antigen receptor T-cell manufactureMaeve A O'Reilly, Aman Malhi, Kathleen P L Cheok, et al.
Haematologica|April 2, 2026
CAR-T therapy for relapsed/refractory large B-cell lymphoma in people living with HIV: efficacy, toxicity and treatment considerationsAngela Hwang, Amy A Kirkwood, Prudence Hardefeldt, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 13, 2006
Long-term outcomes of myeloablation and autologous transplantation of relapsed acute myeloid leukemia in second remission: a British Society of Blood and Marrow Transplantation registry studyAndrew D Chantry, John A Snowden, Charles Craddock, et al.
Molecular Therapy. Methods & Clinical Development|October 27, 2023
Large-scale manufacturing of base-edited chimeric antigen receptor T cellsRosie Woodruff, Farhaan Parekh, Katarina Lamb, et al.
Bone|April 29, 2006
Elevated serum FGF23 concentrations in plasma cell dyscrasiasInge Stewart, Claire Roddie, Anthony Gill, et al.
Hemasphere|March 4, 2024
High pretreatment disease burden as a risk factor for infectious complications following CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphomaMaeve A O'Reilly, Lorna Neill, Simon M Collin, et al.
Pageof 7